Supportive Care
  • Featured content
    In this downloadable slideset, Suresh S, Ramalingam, MD, uses cases to provide insights for the management of patients with advanced NSCLC experiencing toxicities with immune checkpoint inhibitors.
    Date Posted: 6/9/2017
  • Featured content
    In this downloadable slideset, M. Dror Michaelson, MD, PhD, explores the data and clinical guidelines on the optimal use of immune checkpoint inhibitors for treating renal cell carcinoma.
    Date Posted: 6/7/2017
  • Featured content
    In this downloadable slideset, Elizabeth R. Plimack, MD, MS, discusses the data and clinical guidelines on the optimal use of immune checkpoint inhibitors for treating advanced urothelial cell carcinoma.
    Date Posted: 6/7/2017
  • Featured content
    Download this pocket guide for information on dosing, administration, and clinical management for the current FDA-approved checkpoint inhibitor, nivolumab, in advanced RCC. This pdf includes a checklist for assessing your patients for common immune-related adverse events in the clinic.
    Date Posted: 5/24/2017
  • Featured content
    Anas Younes, MD, discusses standards of care for patients with or at risk of TLS, including risk stratification and optimal use of available agents for prophylaxis and treatment of TLS.
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Content

10 of 78 Shown
10 of 78 Shown
Show 10 More
Loading...